| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849923 | American Journal of Kidney Diseases | 2010 | 8 Pages |
Abstract
Our data show that eAG calculated from HbA1c and fructosamine levels might underestimate mean blood glucose levels in patients with CKD stages 3-4. References ranges may need to be modified when interpreting results of measurements of glycemic control in type 2 diabetic patients with CKD.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Harn-Shen MD, PhD, Tzu-En MD, Hong-Da MD, Tjin-Shing MD, Li-Chuan BSC, Shen-Hung BSC, Shu-Hsia BSC,